Priser
Platform
Blog
Om os
Download
300298
Sinocare
Shenzhen Stock Exchange
0

Om

Sinocare Inc. is a leading provider of diabetic management solutions, primarily focused on the development, manufacturing, and sale of blood glucose monitoring systems. Situated at the crossroads of healthcare and technology, Sinocare capitalizes on China's expanding medical needs due to a growing prevalence of diabetes. The company produces a wide range of products including glucose meters, test strips, and biosensor technology, all aimed at facilitating easy and accurate monitoring of blood sugar levels. Sinocare's innovations have a significant impact on both the healthcare and medical device sectors, addressing a critical need for accessible diabetes management solutions. By leveraging advanced biosensor technology, Sinocare is committed to improving the quality of life for diabetic patients not just in China, but increasingly on a global scale. The company's operations and continuous research reflect its solid standing and the pivotal role it plays in the burgeoning health-technology arena.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I SINOCARE MED ENDAVU: Køb Sinocare ($300298) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Sinocare, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker300298
Land
Kina
Antal medarbejdere4.809
Hjemmesidesinocare.com
SektorSundhed
IndustriMedicinsk udstyr

Udbytter

0,3CNH
'20
0,2CNH
'21
0,2CNH
'22
0,2CNH
'23
0,2CNH
'24
0,22CNH
'25
Ex-udbytte-dato13. jun. 2025
Udbytteafkast1,29%

Analytikerskøn

Baseret på 4 analytikere

Stærkt købKøbHoldSælgStærkt sælg
25%75%0%0%0%